Update on the Impact of Comorbidities on the Efficacy and Safety of Heart Failure Medications

被引：0
|
作者：
Christine Chow
Robert J. Mentz
Stephen J. Greene
机构：
[1] Duke University School of Medicine,Division of Cardiology
[2] Duke University School of Medicine,undefined
[3] Duke Clinical Research Institute,undefined
来源：
Current Heart Failure Reports | 2021年 / 18卷
关键词：
Heart failure; Comorbidities; SGLT2 inhibitors; Sacubitril-valsartan; Mineralocorticoid receptor antagonists; Beta-blockers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：132 / 143
页数：11
相关论文
共 50 条
  • [1] Update on the Impact of Comorbidities on the Efficacy and Safety of Heart Failure Medications
    Chow, Christine
    Mentz, Robert J.
    Greene, Stephen J.
    CURRENT HEART FAILURE REPORTS, 2021, 18 (03) : 132 - 143
  • [2] The impact of comorbidities on the physical and psychological dimension in heart failure patients
    Iovanovici, Diana Carina
    Bungau, Simona Gabriela
    Purza, Anamaria Lavinia
    Tit, Delia Mirela
    Antal, Ioan Andrei
    Cseppento, Carmen Delia Nistor
    Toma, Mirela Marioara
    Dogaru, Bombonica Gabriela
    BALNEO AND PRM RESEARCH JOURNAL, 2024, 15 (02):
  • [3] Proteomics of human heart failure: effects of mutations, medications and comorbidities
    Barreiro, Javier Barallobre
    Radovits, Tamas
    Fava, Marika
    Ragone, Isabella
    Kovacs, Attila
    Ziani, Leila
    Daroczi, Laszlo
    Barta, Balint
    Schmidt, Lukas
    Theofilatos, Konstantinos
    Crespo Leiro, Maria Generosa
    Domenech, Nieves
    Merkely, Bela
    Mayr, Manuel
    HEART, 2023, 109 : A248 - A248
  • [4] Heart failure and comorbidities
    Boully, Clemence
    Hanon, Olivier
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2015, 13 : 13 - 22
  • [5] Preheart failure comorbidities and impact on prognosis in heart failure patients: a nationwide study
    Christiansen, M. N.
    Kober, L.
    Torp-Pedersen, C.
    Gislason, G. H.
    Schou, M.
    Smith, J. G.
    Vasan, R. S.
    Andersson, C.
    JOURNAL OF INTERNAL MEDICINE, 2020, 287 (06) : 698 - 710
  • [6] The Impact of Frailty and Comorbidities on Heart Failure Outcomes
    Salmon, Thomas
    Essa, Hani
    Tajik, Behnam
    Isanejad, Masoud
    Akpan, Asangaedem
    Sankaranarayanan, Rajiv
    CARDIAC FAILURE REVIEW, 2022, 8
  • [7] Molecular remodeling in comorbidities associated with heart failure: a current update
    Appunni, Sandeep
    Rubens, Muni
    Ramamoorthy, Venkataraghavan
    Saxena, Anshul
    Mcgranaghan, Peter
    Khosla, Atulya
    Doke, Mayur
    Chaparro, Sandra
    Jimenez, Javier
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [8] Efficacy and Safety of Sacubitril/valsartan in Patients with Heart Failure
    Alhabeeb, Waleed
    Al Ayoubi, Fakhr
    Hayajneh, Ahmad
    Elshaer, Fayez
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2020, 9 (04): : 11 - 18
  • [9] Heart Failure and Comorbidities—Part 2
    Andre Rodrigues Duraes
    Wallace André Pedro da Silva
    Conrado Roberto Hoffmann Filho
    Yasmin de Souza Lima Bitar
    Mansueto Gomes Neto
    Current Emergency and Hospital Medicine Reports, 2020, 8 : 69 - 75
  • [10] Patterns of comorbidities differentially impact on in-hospital outcomes in heart failure patients
    Veronica Murru
    Elena Belfiori
    Alessandro Sestu
    Andrea Casanova
    Carla Serra
    Angelo Scuteri
    BMC Geriatrics, 25 (1)
12345